题名 | Dual Inhibition of HIV-1 and Cathepsin L Proteases by Sarcandra glabra |
作者 | |
通讯作者 | Zhou, Ying; Yang, Jian; Wei, Ying |
发表日期 | 2022-09-01
|
DOI | |
发表期刊 | |
EISSN | 1420-3049
|
卷号 | 27期号:17 |
摘要 | The COVID-19 pandemic continues to impose a huge threat on human health due to rapid viral mutations. Thus, it is imperative to develop more potent antivirals with both prophylactic and treatment functions. In this study, we screened for potential antiviral compounds from Sarcandra glabra (SG) against Cathepsin L and HIV-1 proteases. A FRET assay was applied to investigate the inhibitory effects and UPLC-HRMS was employed to identify and quantify the bioactive components. Furthermore, molecular docking was carried out to get a glimpse of the binding of active compounds to the proteases. Our results showed that the SG extracts (SGW, SG30, SG60, and SG85) inhibited HIV-1 protease with an IC50 of 0.003 similar to 0.07 mg/mL and Cathepsin L protease with an IC50 of 0.11 similar to 0.26 mg/mL. Fourteen compounds were identified along with eight quantified from the SG extracts. Chlorogenic acid, which presented in high content in the extracts (12.7 similar to 15.76 mu g/mg), possessed the most potent inhibitory activity against HIV-1 protease (IC50 = 0.026 mg/mL) and Cathepsin L protease (inhibition: 40.8% at 0.01 mg/mL). Thus, SG extracts and the active ingredients could potentially be used to prevent/treat viral infections, including SARS-CoV-2, due to their dual-inhibition functions against viral proteases. |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 其他
|
资助项目 | Guizhou Provincial Science and Technology Projects["(2020)4Y213","ZK [2022] general 480"]
; Innovation Group Project of Guizhou Province[(2021)018]
; Research Center of Molecular Bioactivity from Traditional Chinese Medicine and Ethnomedicine[3411-4110000520364]
; Shenzhen Fund for Guangdong Provincial High-Level Clinical Key Specialties[SZXK059]
; projects of Guizhou Province["gzwkj2022-232","gzwkj2022-467","[2022]253"]
; projects of Guizhou University of Traditional Chinese Medicine["2018YFC170810204","2018YFC170810108"]
|
WOS研究方向 | Biochemistry & Molecular Biology
; Chemistry
|
WOS类目 | Biochemistry & Molecular Biology
; Chemistry, Multidisciplinary
|
WOS记录号 | WOS:000851748300001
|
出版者 | |
ESI学科分类 | CHEMISTRY
|
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:5
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/401515 |
专题 | 南方科技大学医学院_药理学系 南方科技大学第一附属医院 |
作者单位 | 1.Guizhou Univ Tradit Chinese Med, Coll Pharm, Guiyang 550025, Peoples R China 2.Southern Univ Sci & Technol, Jinan Univ, Affiliated Hosp 1,Dept Pharmacol, Shenzhen Peoples Hosp,Clin Med Coll 2, Shenzhen 518020, Peoples R China 3.Univ Saskatchewan, Coll Pharm & Nutr, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada |
推荐引用方式 GB/T 7714 |
Pan, Bowen,Li, Sumei,Xiao, Junwei,et al. Dual Inhibition of HIV-1 and Cathepsin L Proteases by Sarcandra glabra[J]. MOLECULES,2022,27(17).
|
APA |
Pan, Bowen.,Li, Sumei.,Xiao, Junwei.,Yang, Xin.,Xie, Shouxia.,...&Wei, Ying.(2022).Dual Inhibition of HIV-1 and Cathepsin L Proteases by Sarcandra glabra.MOLECULES,27(17).
|
MLA |
Pan, Bowen,et al."Dual Inhibition of HIV-1 and Cathepsin L Proteases by Sarcandra glabra".MOLECULES 27.17(2022).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论